Literature DB >> 21903938

MicroRNA-29 in aortic dilation: implications for aneurysm formation.

Reinier A Boon1, Timon Seeger, Susanne Heydt, Ariane Fischer, Eduard Hergenreider, Anton J G Horrevoets, Manlio Vinciguerra, Nadia Rosenthal, Sergio Sciacca, Michele Pilato, Paula van Heijningen, Jeroen Essers, Ralf P Brandes, Andreas M Zeiher, Stefanie Dimmeler.   

Abstract

RATIONALE: Aging represents a major risk factor for coronary artery disease and aortic aneurysm formation. MicroRNAs (miRs) have emerged as key regulators of biological processes, but their role in age-associated vascular pathologies is unknown.
OBJECTIVE: We aim to identify miRs in the vasculature that are regulated by age and play a role in age-induced vascular pathologies. METHODS AND
RESULTS: Expression profiling of aortic tissue of young versus old mice identified several age-associated miRs. Among the significantly regulated miRs, the increased expression of miR-29 family members was associated with a profound downregulation of numerous extracellular matrix (ECM) components in aortas of aged mice, suggesting that this miR family contributes to ECM loss, thereby sensitizing the aorta for aneurysm formation. Indeed, miR-29 expression was significantly induced in 2 experimental models for aortic dilation: angiotensin II-treated aged mice and genetically induced aneurysms in Fibulin-4(R/R) mice. More importantly, miR-29b levels were profoundly increased in biopsies of human thoracic aneurysms, obtained from patients with either bicuspid (n=79) or tricuspid aortic valves (n=30). Finally, LNA-modified antisense oligonucleotide-mediated silencing of miR-29 induced ECM expression and inhibited angiotensin II-induced dilation of the aorta in mice.
CONCLUSION: In conclusion, miR-29-mediated downregulation of ECM proteins may sensitize the aorta to the formation of aneurysms in advanced age. Inhibition of miR-29 in vivo abrogates aortic dilation in mice, suggesting that miR-29 may represent a novel molecular target to augment matrix synthesis and maintain vascular wall structural integrity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903938     DOI: 10.1161/CIRCRESAHA.111.255737

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  140 in total

Review 1.  The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.

Authors:  Alison J Kriegel; Yong Liu; Yi Fang; Xiaoqiang Ding; Mingyu Liang
Journal:  Physiol Genomics       Date:  2012-01-03       Impact factor: 3.107

2.  Translational Regulation of the Mitochondrial Genome Following Redistribution of Mitochondrial MicroRNA in the Diabetic Heart.

Authors:  Rajaganapathi Jagannathan; Dharendra Thapa; Cody E Nichols; Danielle L Shepherd; Janelle C Stricker; Tara L Croston; Walter A Baseler; Sara E Lewis; Ivan Martinez; John M Hollander
Journal:  Circ Cardiovasc Genet       Date:  2015-09-16

Review 3.  30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature.

Authors:  Jennifer J DuPont; Iris Z Jaffe
Journal:  J Endocrinol       Date:  2017-07       Impact factor: 4.286

Review 4.  Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis.

Authors:  Mingyi Wang; Soo Hyuk Kim; Robert E Monticone; Edward G Lakatta
Journal:  Hypertension       Date:  2015-02-09       Impact factor: 10.190

Review 5.  Bicuspid aortic valve aortopathy: genetics, pathophysiology and medical therapy.

Authors:  Nada Abdulkareem; Jeremy Smelt; Marjan Jahangiri
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-31

6.  Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction.

Authors:  Aurelia De Pauw; Emilie Andre; Belaid Sekkali; Caroline Bouzin; Hrag Esfahani; Nicolas Barbier; Axelle Loriot; Charles De Smet; Laetitia Vanhoutte; Stéphane Moniotte; Bernhard Gerber; Vittoria di Mauro; Daniele Catalucci; Olivier Feron; Denise Hilfiker-Kleiner; Jean-Luc Balligand
Journal:  JCI Insight       Date:  2017-06-15

7.  Prevention of abdominal aortic aneurysm by anti-microRNA-712 or anti-microRNA-205 in angiotensin II-infused mice.

Authors:  Chan Woo Kim; Sandeep Kumar; Dong Ju Son; In-Hwan Jang; Kathy K Griendling; Hanjoong Jo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-08       Impact factor: 8.311

8.  MicroRNA-34a regulates cardiac ageing and function.

Authors:  Reinier A Boon; Kazuma Iekushi; Stefanie Lechner; Timon Seeger; Ariane Fischer; Susanne Heydt; David Kaluza; Karine Tréguer; Guillaume Carmona; Angelika Bonauer; Anton J G Horrevoets; Nathalie Didier; Zenawit Girmatsion; Peter Biliczki; Joachim R Ehrlich; Hugo A Katus; Oliver J Müller; Michael Potente; Andreas M Zeiher; Heiko Hermeking; Stefanie Dimmeler
Journal:  Nature       Date:  2013-02-20       Impact factor: 49.962

Review 9.  The plaque "micro" environment: microRNAs control the risk and the development of atherosclerosis.

Authors:  Katey J Rayner; Kathryn J Moore
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

10.  MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms.

Authors:  Claudia Goettsch; Joshua D Hutcheson; Elena Aikawa
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.